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Abstract 
Single injections of recombinant cytokinedchemokines into tissue have provided insights into their possible roles 
during the inflammatory response. Adenoviral technology may allow us to mimic the in vivo situation more 
closely, with protein generated in a continuous but transient fashion. Replication-deficient human type 5 
adenovirus containing a rat macrophage inflammatory protein-2 (MIf-2) gene insertion and cytomegalovirus 
promoter was injected into the mouse brain to investigate the inflammatory response to continuous 
overproduction of MIP-2. Adenovirus with a LacZ gene insertion expressing P-galactosidase was used as a 
control. At doses of l o 4  to lo7 plaque-forming units, a minimal inflammatory response was detected to the LacZ 
virus, with leukocyte recruitment that was restricted to the injection site. A dose of lo7 plaque-forming units of 
both the LacZ and the MIf-2 vector produced extensive transgene product expression that persisted for at least 
7 days. Astrocytes, recognized by their morphology, were the predominant cell type expressing MIP-2 and 
P-galactosidase. A dose of 1 O7 plaque-forming units of MP-2 vector caused dramatic polymorphonuclear 
leukocyte (PMN) recruitment to the brain parenchyma after 2 days. PMN recruitment was still observed after 
4 and 7 days, but had become more localized to the injection site and was associated with numerous foam-like 
macrophages. At both 2 and 7 days the blood-brain barrier was breached in the region of leukocyte recruitment. 
Despite the extent of leukocyte recruitment there were no overt signs of neuronal degeneration or demyelination. 
Our findings demonstrate that continuous production of MIP-2 in the CNS results in persistent PMN recruitment 
to the brain parenchyma with no evidence of tachyphylaxis. The lack of PMN recruitment to the brain 
parenchyma following CNS injury may be a result of deficient production of PMN chemoattractants. 
Introduction 
Previous studies have demonstrated that the CNS is resistant to 
polymorphonuclear leukocyte (PMN) recruitment following the injec- 
tion of various proinflammagens or during acute neuronal degeneration 
(Anderson et al., 1991, 1992a, b). Similarly, in many neurological 
diseases, such as multiple sclerosis, experimental allergic encephalo- 
myelitis, Alzheimer’s disease and Parkinson’s disease, PMNs appear 
to be excluded from the brain parenchyma and leukocyte recruitment 
is restricted to T-cells and monocytes (Traugott et al., 1983; Itagaki 
et al., 1988; McGeer et al., 1994). Macrophage inflammatory protein- 
2 (MIP-2) is a rodent a-chemokine with potent chemoattractant 
activity for PMNs in vitro and in vivo (Wolpe et al., 1989; Wolpe 
and Cerami, 1989). We have recently demonstrated that recombinant 
murine MIP-2 and human interleukin (IL)-8 will produce dramatic 
PMN recruitment to the murine brain parenchyma when injected 
intracranially (M. D. Bell, D. D. Taub and V. H. Perry, submitted for 
publication). In vivo, cytokines and chemoattractants will be produced 
continuously at high concentrations into the local environment. Single 
bolus injections of recombinant proteins may not accurately reflect 
their roles during tissue inflammation. In contrast, continued exposure 
of the environment to chemoattractants such as MIP-2 may result in 
rapid tachyphylaxis. 
The biological function of cytokines or chemokines may be 
examined in a more physiological setting using a novel delivery 
system. Viruses may be used as vectors to transfer protein genes or 
cDNA into target tissue. Infection of rapidly dividing cells has been 
successfully achieved using retroviral vectors (Rosenberg et al., 1988; 
Wolff et al., 1989). These, however, are unable to infect fully 
differentiated cells with low turnover, such as glial cells and neurons 
of the brain. Adenoviruses, on the other hand, are capable of infecting 
postmitotic cells such as hepatocytes (Jaffe et al., 1992; Herz and 
Gerard, 1993), myotubules (Quantin et al., 1992; Stratford-Perricaudet 
et al., 1992), endothelial cells (Lemarchand er al., 1992) and lung 
epithelial cells (Rosenfeld et al., 1992; Xing et al., 1994). Recently, 
adenovirus-mediated gene transfer has been applied to the CNS where 
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infection of glial cells (Akli et al., 1993; Le Gal La Salle et al., 
1993), ependymal cells (Akli et al., 1993; Bajocchi et al., 1993) and 
neurons (Akli et al., 1993; Davidson et al., 1993; Le Gal La Salle 
et al., 1993) has been demonstrated with more prolonged transgene 
expression than with infection in other tissues. 
The use of human recombinant type 5 adenoviruses expressing 
rodent IL-6 and IL-2 genes has been shown previously (Braciak 
et al., 1993; Xing et al., 1994; Addison et al., 1995). In the current 
study, we have used the same vector system with a rat MIP-2 gene 
insertion. We have examined the biological effect of prolonged but 
transient expression of the transgene in the CNS, mimicking an 
in vivo inflammatory episode. A vector with a LmZ gene insertion 
coding for P-galactosidase was used as a control to examine back- 
ground inflammatory responses to the virus itself. 
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Materials and methods 
Recombinant adenovirus vectors 
The construction of similar recombinant human type 5 adenovirus 
has been well characterized previously (Braciak et al., 1993). Viruses 
were made replication-deficient by deleting El  and rat MIP-2 cDNA 
inserted into the E3 region of the genome. Rat MIP-2 has previously 
been cloned and has a base sequence homology of 90.3% with 
murine MIP-2 (Driscoll et al., 1995). A human cytomegalovirus 
promoter and SV40 polyadenylation sequence were inserted upstream 
and downstream of the MZP-2 cDNA respectively (Ad5MIP-2). 
Replication-deficient recombinant human type 5 adenovirus with 
Escherichia coli P-galactosidase cDNA (Ad5LacZ) in the E3 region 
was constructed in a similar way. Virus was purified by CsCl gradient 
centrifugation and dialysed against autoclaved Tris-HC1 buffer, 
pH 7.4, containing 10% glycerol. 
Establishment of brain infection 
Adult BALB/c mice, 8-12 weeks old, were obtained from the Sir 
William Dunn School of Pathology (Oxford University). Animals 
were anaesthetized with avertin (0.1 mV5 g body weight of 1.25% 
wtlvol tribromoethanol in 2.5% voVvol amyl alcohol) and atropine 
(0.6 pg/g body weight). The animals were held in a stereotaxic 
apparatus and 0.5 p1 of AdSLacZ or Ad5MIP-2, at doses ranging 
from lo4 to lo7 plaque-forming units (p.f.u.) per 0.5 pl, was 
injected in endotoxin-free phosphate-buffered saline into the dorsal 
hippocampus. Injections were made with finely drawn glass micro- 
pipettes at the stereotaxic coordinates: bregma -2.5, lateral 1.8 and 
depth 1.5 mm. Monastral blue (Sigma) was included as an inert 
tracer. Animals were left for 2, 4, 7 or 14 days before they were 
deeply anaesthetized and killed by perfusion. See Table 1 for numbers 
of animals used. 
Assessment of blood-brain barrier permeability 
Animals were injected intravenously with 3 mg (510 units) of 
horseradish peroxidase (type 11; Sigma) in 100 p1 of 0.9% (wtlvol) 
saline 20 min before perfusion fixation. Using a cryostat, 50 pm 
sections were cut through the injection site and peroxidase activity 
in the brain was detected using a modified Hanker-Yates method 
(Perry and Linden, 1982) 
Tissue preparation 
Mice were deeply anaesthetized with avertin and transcardial 
perfusion was initiated with heparinized saline followed by fixative 
containing 2% paraformaldehyde-lysine-periodate (McLean and 
TABLE 1.  Animal numbers and survival times following AdSMIP-2 or 
AdSLacZ injection 
Days after adenovirus injection 
p.f.u./0.5 p1 2 days 4 days 7 days 14 days 
AdSLacZ 10‘ 2 
lo” 2 
I 06 2 2 
I o7 4 2 4 2 
Ad5MIP-2 lo4 2 
I o5 2 
106 2 2 
I o7 4 2 4 2 
Nakane, 1974) and 0.05% glutaraldehyde. The tissue was postfixed 
for a further 4-6 h in the same fixative at 4°C. For cryoprotection, 
tissue was left overnight in 25% sucrose in phosphate-buffered saline 
before embedding in Tissue Tek OCT (Miles) and being rapidly 
frozen in liquid nitrogen. Sections (10 pm) were cut using a cryostat 
and were air-dried. 
lmmunohistochemistry and leukocyte identification 
Antigens expressed by the different leukocyte populations were 
localized by immunohistochemistry using the following primary 
antibodies. Expression of transgene product was assessed using 
a rabbit polyclonal antibody against P-galactosidase (a gift from 
Dr M. Wood) and a rabbit polyclonal antibody against murine MIP- 
2 previously characterized by Dr S. L. Kunkel (Lucas er a/., 1995). 
Macrophages were identified using F4/80, a rabbit polyclonal antibody 
against a 160 kDa membrane glycoprotein expressed by most tissue 
macrophages (Austyn and Gordon, 1981). and TIB120 rat mono- 
clonal against major histocompatibility complex (MHC) class I1 
(Bhattacharya et al., 1981 ). Resident microglia were distinguished 
from macrophages by their ramified appearance. PMNs were identified 
by their polylobed nuclei stained with cresyl violet and the monoclonal 
antibody TIB122 against the leukocyte common antigen (Springer 
et al., 1978). The term ‘polymorphonuclear leukocyte’ is synonymous 
with the term ‘neutrophil’. We cannot exclude the presence of rare 
eosinophilic and basophilic granulocytes in the infiltrates to the CNS 
parenchyma. CD4- and CD8-positive lymphocytes were identified 
using monoclonal antibodies YTS 191.1 and YTS 169.4 respectively 
(Cobbold et al., 1984). Endothelial activation was detected using a 
rat monoclonal antibody against murine intercellular cell adhesion 
molecule-I (ICAM-1) (Takei, 1985; Horley et al., 1989). The tissue 
was incubated with the primary antibody for 90 min at room 
temperature. Antibody binding was detected using the avidin-biotin 
peroxidase method with diaminobenzidine as the chromogen (Hsu 
et al., 1981). Non-specific Fc binding was prevented by preincubation 
with normal serum and non-specific peroxidase activity eliminated 
by the glucose oxidase method (Locksley et al., 1983). Control 
sections were treated in the same way, omitting incubation with the 
primary antibody. 
Resu I ts 
AdSLacZ injection caused minimal brain inflammation 
AdSLacZ injections were carried out to examine the inflammatory 
response mounted against the virus. We could then determine the 
contribution made by MIP-2 to the inflammatory response following 
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FIG. 1. Micrographs showing CNS response and protein expression after the intracranial injections of lo7 p.f.u. of AdSLacZ or Ad5MIP-2. (A) Staining with 
anti-ICAM- 1 antibody 2 days after the intracranial injection of AdSLacZ indicates widespread ICAM- I up-regulation on the endothelium ( m o w ) .  Note minimal 
leukocyte recruitment, which is restricted to the injection site (leu). (B, C) Staining with anti-P-galactosidase. Expression of P-galactosidase is widespread in 
the injected hippocampus (B) and is especially clear on cells with astrocyte-like morphology (C). (D) ME'-2 expression detected with anti-murine MIP-2 
antibody 7 days following the intracranial injection of 10' p.f.u. AdSMIP-2. Note expression by astrocyte-like cells (arrow) in the presence of dramatic 
polymorphonuclear leukocyte recruitment. Scale bar for B = 100 pm. Scale bar for A, C and D = 50 pm. 
Ad5MIP-2 injection. P-Galactosidase, the product of AdSLacZ, does 
not elicit an inflammatory response (Bymes et al., 1995). 
At all doses, Ad5LacZ injection produced minimal leukocyte 
recruitment to the brain parenchyma and meninges (Fig. 1A). After 
2 days, a dose of lo6 p.f.u. produced morphological up-regulation of 
microglia throughout the injected hippocampus. ICAM-1 expression 
on endothelium showed a similar distribution (Fig. 1A). At lower 
doses, activation of microglia and endothelium was restricted to the 
injection site. Injections of lo6 or lo7 p.f.u. of virus caused MHC 
class 11 expression on reactive microglia with a distribution similar 
to that for P-galactosidase expression. Rounded macrophages 
expressing MHC class II were confined to the injection site and 
meninges. Small numbers of CD4- and CD8-positive T-cells in about 
equal numbers were recruited to the injection site and meninges after 
lo6 and lo7 p.f.u. Small numbers of PMNs were only observed at 
the injection site following the highest dose. Leukocyte recruitment 
to the parenchyma 4 days after lo7 p.f.u. AdSLacZ was similar to 
that observed after 2 days. Small numbers of macrophages, T-cells 
and PMNs were observed at the injection site and in the meninges. 
By 7 days, occasional T-cells still remained in the parenchyma and 
meninges. Microglia had returned to their resting phenotype except 
in the injection tract, and the endothelium no longer expressed 
ICAM-1. No overt cytopathic effects of the virus were detected at 
any time point. 
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FIG. 2. Sections stained with cresyl violet indicating negligible polymorphonuclear leukocyte recruitment 2 days following the intracranial injection of lo7 p.f.u. 
AdSLacZ (A) compared with the dramatic recruitment 2 days following the injection of lo7 p.f.u. AdSMIP-2 (B).  Scale bar = I 0 0  prn. 
Astrocytes are the predominant cell type expressing transgene 
products 
No protein expression was observed following the injection of lo4 
or lo5 p.f.u. of virus. A dose of lo6 p.f.u. AdSLacZ was sufficient 
to cause P-galactosidase expression but no MIP-2 expression was 
observed after the same dose of AdSMIP-2 was injected. A dose 
of lo7 p.f.u. of Ad5LacZ or Ad5MIP-2 caused extensive protein 
expression in the brain parenchyma which persisted for up to 7 days. 
After 2 days, protein expression was observed around the injection 
site and following axonal tracts in the cortical white matter and 
corpus callosum (Fig. 1B). Astrocytes recognized by their morphology 
were the principal source of transgene product in grey and white 
matter (Fig. IC). Expression could also be observed on occasional 
endothelial cells and cells with neuronal morphology in the CAI. 
A similar distribution was observed 4 days after the injection. By 
7 days, the same cell types were observed to express protein but 
expression was localized to the injection site. Expression of p- 
galactosidase was still detected at the injection site 14 days after 
AdSLacZ injection. MIP-2 expression following AdSMIP-2 injection 
was, after the same time, restricted to rare glial processes around the 
injection site. At earlier time points MIP-2 expression was associated 
with PMN recruitment (Fig. 1D). 
PMN recruitment in response to Ad5MIP-2 brain infection 
At all doses, the rnicroglial activation 2 days following AdSMIP-2 
injection cells was similar to that observed after AdSLacZ 
injection, as was the endothelial ICAM-1 expression and the recruit- 
ment of T-cells. Whereas the AdSLacZ caused minimal PMN 
recruitment (Fig. 2A), a dose of lo7 AdSMIP-2 elicited extensive 
PMN recruitment after 2 days (Figs 2B and 3A). PMNs were present 
in the white matter and the dendritic fields of the CA1 pyramidal 
cells, and were observed cuffing large vessels in the hippocampal 
fissure. PMN recruitment was associated with MIP-2 expression. Few 
PMNs were observed in the meninges and there was no evidence of 
choroiditis. Numerous fragmented nuclei and pyknotic cells were 
also detected, indicating dying PMNs. Low numbers of PMNs were 
also observed following lo6 p.f.u. (more PMNs than were seen after 
the same dose of AdSLacZ), despite the inability to detect any MIP- 
2 by immunohistochemistry. 
Florid PMN recruitment was still observed 4 days after the 
injection of lo7 p.f.u. AdSMIP-2. PMNs were interspersed with 
numerous F4/80-positive round macrophages which resembled foam 
cells (Fig. 3B). After 7 days leukocyte recruitment was more localized 
to the original injection site (Fig. 3C). Healthy PMNs and macrophages 
were still present in large numbers surrounding large vessels at the 
injection site itself. Pyknotic nuclei, presumably those of PMNs, 
could be observed within occasional macrophages. Macrophage 
recruitment was not observed 4 or 7 days after the AdSLacZ 
injection and hence must be related to MIP-2 expression. No overt 
demyelination or neuronal damage was detected at any time. 
After 14 days, primarily PMN restricted leukocyte recruitment was 
still detected around the injection site (Fig. 3D). The number of 
recruited cells was much reduced from 7 days. 
Leukocyte recruitment following Ad5MIP-2-2 injection was 
associated with breaching of the blood-brain barrier 
A dose of lo7 p.f.u. AdSLacZ produced breakdown of the blood- 
brain barrier (BBB) that was largely restricted to the injection site 
(Fig. 4A). In contrast, a similar dose of AdSMIP-2 produced extensive 
breakdown of the BBB after 2 days. (Fig. 4B). Horseradish peroxidase 
and IgG could be localized to areas of PMN recruitment. This 
breakdown was prolonged since it was still evident after 7 days (Fig. 
4C), but by 14 days (Fig. 4D) it was restricted to the original 
injection site. 
Discussion 
In the present study we have used an adenoviral transgene system 
to explore the biological effect of continuous MIP-2 expression in 
the brain. Doses ranging from lo4 to lo7 p.f.u. of AdSLacZ and 
AdSMIP-2 were injected into the dorsal hippocampus and immuno- 
histochemistry was used to investigate the inflammatory response. 
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FIG. 3. Micrographs showing leukocyte recruitment following the intracranial injection of lo7 p.f.u. Ad5MIP-2. After 2 days, staining with cresyl violet indicates 
dramatic polymorphonuclear leukocyte recruitment, especially in the white matter (A). After 4 days (B) and 7 days (C), staining with F4/80 polyclonal antibody 
reveals numerous recruited macrophages interspersed with polymorphonuclear leukocytes. After 14 days, polymorphonuclear leukocyte recruitment is still 
observed at the injection site shown in D with anti-leukocyte common antigen staining. Scale bar = 50 pm. 
An intracranial injection of AdSLacZ at lo7 p.f.u. caused microglial 
activation but minimal leukocyte recruitment to the brain parenchyma. 
Both vectors were mainly targeted to astrocytes, which expressed 
high levels of the transgene products for at least 7 days following 
the injection. Whereas AdSLacZ infection resulted in negligible PMN 
recruitment, AdSMIP-2 resulted in dramatic PMN recruitment to 
the brain parenchyma after 2 days. Surprisingly, PMN recruitment 
persisted after 4 and 7 days but had become more localized to 
the injection site and was associated with numerous foam-like 
macrophages. Breakdown of the BBB was restricted to the injection 
site following AdSLacZ injection, but following the AdSMIP-2 
injection BBB breakdown was dramatic in areas of leukocyte infiltra- 
tion at both 2 and 7 days. 
The CNS inflammatory response to virus 
One caveat that arises from adenovirus gene transfer into tissue is the 
host inflammatory or immune response mounted against the virus. This 
may influence the biological effect of the transgene products under 
study and make interpretation difficult. In the CNS, this may be less of 
a problem given the relatively down-regulated nature of inflammatory 
and immune responses when compared with those in non-CNS tissues. 
In other tissues, both cellular and humoral immune responses have been 
described in response to adenovirus injection (Yang et al., 1994). The 
more prolonged expression in neonates and immunosuppressed adults 
indicates that the immune response contributes to the limited duration 
of transgene product expression (Kass-Eisler et al., 1994; Yang et al., 
1994). Within the CNS, we and other laboratories have reported that 
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FIG. 4. Micrographs showing permeability of the blood-brain barrier to intravenous horseradish peroxidase following the intracranial injection of lo7 p.f.u. 
Ad5LacZ or Ad5MIP-2. Extent of peroxidase staining was similar to IgG staining (not shown). (A) Blood-brain barrier breakdown was restricted to the injection 
site 2 days following AdSLacZ. (B) Blood-brain barrier breakdown was more extensive 4 days after AdSMIP-2. Breakdown was still observed after 7 days (C) 
and by 14 days was restricted to the injection site (D). Scale bar = 500 pm. 
the inflammatory response is minimal in the CNS with microglial 
activation but negligible leukocyte recruitment (Anderson et al., 1991, 
1992a. b; Le Gal La Salle et al., 1993; Horellou et al., 1994). This may 
be one reason for the prolonged expression, for up to 2 months, of 
transgene products in the CNS (Davidson et al., 1993; Byrnes et al., 
1995). Strain differences must be borne in mind, given a recent study 
that detailed the inflammatory response to AdSLacZ injection in rat 
brain. The severity of the inflammatory response was found to depend 
on the strain of rat used (Bymes et al., 1995). In the current study, the 
inflammatory response produced following infection with AdSMIP-2 
could be almost solely attributed to expression of the MIP-2 protein. 
Transgene product expression 
The cell types that are infected and express the transgene products 
are an important consideration when investigating the function of 
chemokines in vivo. Ideally, the adenovirus would be targeted to the 
natural producers of chemokines during inflammation. In experimental 
allergic encephalomyelitis, astrocytes appear to be the principal source 
of the chemokines monocyte chemotactic protein- 1 and interferon- 
y-inducible protein within the CNS parenchyma (Ransohoff et al., 
1993). To further validate this model, MIP-2 appeared to be preferen- 
tially expressed by astrocytes. It is unclear whether this expression 
represents newly synthesized protein or protein that has persisted. 
This may be important as chemokine remaining bound to extracellular 
matrix proteins may still be able to exert a chemotactic effect. Studies 
in non-CNS tissues indicate that mRNA synthesis for transgenes 
transferred by adenovirus vectors can continue for weeks. Human 
cystic fibrosis transporter (CFTR) mRNA transcripts were still 
expressed at significant levels 6 weeks after in vivo Ad-CFTR 
infection of cotton rat airway epithelium (Rosenfeld et al., 1992). 
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Continuous MIP-2 production versus single MIP-2 injection 
Single intracranial injections of a long list of proinflammatory agents, 
including lipopol ysaccharide, f-met-leu-phe, platelet-activating factor, 
IL-I and tumour necrosis factor, provoke minimal PMN recruitment 
to the brain parenchyma when compared with non-CNS tissue sites 
(Anderson et al., 1992a, b). Extremely high, non-physiological doses 
of lipopolysaccharide are required to provoke PMN recruitment to 
the parenchyma. MIP-2 is a powerful PMN chemoattractant in vivo 
and in vitro (Wolpe et al., 1989; Wolpe and Cerami, 1989), and 
murine recombinant MIP-2 and human recombinant IL-8 (M. D. Bell, 
D. D. Taub and V. H. Percy, submitted for publication) are the only 
agents tested that are capable of overriding this resistance. A single 
injection of 1 pg MIP-2 into the murine dorsal hippocampus is 
sufficient to evoke extensive meningitis and PMN recruitment into 
the brain parenchyma with BBB breakdown. Peak PMN recruitment 
is observed after 24 h and is substantially reduced by 2 days. In the 
current study, we have demonstrated that transient but prolonged 
expression of MIP-2 is a similarly powerful stimulus for PMN 
recruitment. 
A single injection of recombinant MIP-2 is likely to diffuse over 
a large distance, and drainage into the CSF may account for the 
extensive meningitis that is observed. The brain parenchyma is not 
so permissive for adenovirus diffusion and so the cell types infected 
remain adjacent to the injection site (Akli et al., 1993). In this 
instance the MIP-2 expressed by infected astrocytes exerts a more 
local effect than the single injections, with PMN recruitment only 
observed where transgene product is expressed. Given the pro- 
pensity for chemokines to bind negatively charged glycosamino- 
glycans (Tanaka, 1993), it is likely that MIP-2 is sequestered by the 
surrounding extracellular matrix and remains associated with the cells 
that synthesize it. This will ensure that the inflammatory response 
does not extend into other tissue areas unnecessarily. 
Tachyphylaxis did not occur in response to continuous MIP-2 
production 
Rapid tachyphylaxis of the brain microenvironment is one mechanism 
proposed to account for the minimal recruitment of PMNs during 
brain inflammation. PMNs are particularly prone to desensitization 
(Ward and Becker, 1968) and repeated exposure to chemotactic 
agonists in vitro results in a decline in responsiveness (for review 
see Colditz, 1991). Within tissues, this can quickly lead to the 
termination of PMN infiltration. In the past, tachyphylaxis has been 
examined by multiple injections into the same tissue site. This is 
unlikely to replicate events during tissue damage or infection, when 
proinflammatory mediators are produced continuously for prolonged 
periods of time. Adenovirus gene transfer is a more physiological way 
in which to investigate desensitization phenomena. Single injections of 
MIP-2 into the brain result in transient PMN recruitment that wanes 
after 48 h. This transient nature of the PMN recruitment is similar to 
that observed in non-CNS tissues with other chemotactic agonists 
(for review see Colditz, 1991). The MIP-2 may be quickly dispersed 
and PMN-derived chemoattractant products are not sufficient to 
maintain PMN recruitment at its previous level. It was perhaps 
surprising that, with continuous MIP-2 expression, PMN infiltration 
was still observed 7 days after the initial adenovirus injection. PMN 
recruitment was not as dramatic as after 48 h but was restricted to 
sites exposed to higher titres of virus at the injection site. The absence 
of PMN recruitment at sites where it had been previously observed 
was not likely to be due to desensitization but rather to the loss of 
transgene product. Densensitization of the plasma leakage response 
to agents such as histamine and bradykinin has been observed in 
guinea-pigs and humans (Lewis and Grant, 1924; Miles and Miles, 
1952; Greaves and Shuster, 1967; Baumgarten et al., 1970). We have 
previously demonstrated that MIP-2-induced breakdown of the BBB 
is leukocyte-dependent. The breakdown of the BBB after 7 days 
would indicate that there is no desensitization in response to the 
granulocyte-derived products responsible for this. 
PMNs and tissue damage 
Many studies have documented the contribution made by the products 
of PMN activation to tissue damage (for review see Weiss, 1989). 
Accumulation of PMNs in the cerebral circulation during models of 
ischaemia-reperfusion injury and cerebral malaria is instrumental in 
causing increases in BBB permeability (Kochanek and Hallenbeck, 
1992; Senaldi et al., 1994). Studies investigating the effects of PMN 
activation on myelin or neurons are scarce. Products of the PMN 
respiratory burst, such as oxygen free radicals, have been shown to 
be toxic to spinal cord neurons in culture (Michikawa et al., 1994). 
Furthermore, studies in vitro indicate that excitatory amino acids may 
be released in response to oxygen radicals (for review see Halliwell, 
1989). In this instance, prolonged PMN recruitment results in disrup- 
tion of the BBB, but there were no signs of overt demyelination or 
neuronal degeneration. MIP-2 does elicit a respiratory burst in PMNs, 
although it is not as powerful a stimulus as IL-8 (Wolpe et ab, 1989), 
but it is unknown whether the PMNs are activated within the brain 
parenchyma. 
Specificity of MIP-2 for PMN recruitment is lost with time 
After 7 days, the specificity of the response for PMNs is lost with 
the appearance of foam-like macrophages in the region of MIP-2 
expression. Whether this is a response to PMN death, PMN-derived 
monocyte chemoattractants or subtle tissue damage not detected by 
light microscopy remains to be elucidated. PMN recruitment on its 
own may be sufficient to drive monocyte recruitment, and hence the 
absence of PMN recruitment during acute neuronal degeneration, for 
example, may be partially responsible for the delayed monocyte 
recruitment. The use of selective antibodies to PMNs would allow 
us to determine whether the macrophage recruitment seen after 
Ad5MIP-2 was dependent on prior PMN recruitment. 
Conclusion 
We have demonstrated that the transfection of brain glial cells with 
an adenovirus expressing rat MIP-2 results in prolonged MIP-2 
expression. PMNs are recruited to the brain parenchyma over an 
extended period of time with little evidence of desensitization. The 
exclusion of PMNs from the brain parenchyma following various 
forms of brain injury may indicate a deficiency in the production of 
PMN chemoattractants. 
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